Entecavir CAS 142217-69-4 API Factory Quality Anti-HBV

Description:

Nomen: Entecavir

CAS: 142217-69-4

Aspectus: Crystallinus Powder Alba

Medicamentum antivirale in curatione Hepatitis B infectio

API High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Descriptio:

Manufacturer Supple cum High puritate et stabulo Quality
Nomen chemicum: Entecavir
CAS: 142217-69-4
Medicamentum antivirale in curatione Hepatitis B infectio
API High Quality, Commercial Production

Chemical Properties:

Nomen chemicum Entecavir
Synonyma 2-Amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-unum
CAS Number 142217-69-4
CATTUS Number RF-API80
Stock Status In Stock, Productio Ascendite usque ad Centum chiliogrammata
Formulae hypotheticae C12H15N5O3
M. Pondus 277.28
Liquescens punctum 249.0~ 252.0℃
Brand Ruifu Chemical

Specifications:

Item Specifications
Aspectus Crystallina pulveris alba
Lepidium sativum IR Effusio infraed spectri specimen experimenti concordare debet cum signo referente
Lepidium sativum HPLC Retentio tempus specimen probati correspondet relationis vexillum
pH 5.5~7.5
Imprimis Rotatione Optica +24.0°-+28.0° (DMF: MeOH=1:1 C=1%)
Substantiae cognatae
Totalis immunditias ≤0.30%
Maximum Impuritas ≤0.10%
Enantiomer ≤0.20%
RELICTUM Solvents
Methanol ≤0.30%
Dichloromethane ≤0.06%
n-Hexane ≤0.029%
Tetrahydrofuran ≤0.072%
N,N-Dimethylformamide ≤0.088%
Toluene ≤0.089%
Aqua Content 5.8%~6.5%
Residere in Ignition ≤0.10%
Metalla gravis ≤20ppm
Assay 98.0%~ 102.0% (C12H15N5O3 calculi anhydroi basis)
Magnitudo particula D90: ≤100µm
Test Standard Enterprise Standard
Consuetudinem API, Medicamentum Antiviralis in Hepatitis B Infectionis curatione adhibitum

Sarcina & Repono:

sarcina: Utrem, aluminium foil, pera, cardboard tympanum, 25kg/Drum, vel secundum exigentiam emptoris.

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, humore et pestis infestatione.

commoda:

1

FAQ:

Applicatio:

Entecavir nova est generatio guanini nucleosidi analogorum oralis medicina curatio Hepatitis B Virus (HBV) infectio, maxime pro curatione aegrorum adultorum cum actione replicatione virali et serum transaminatis continuatum ad augendum, seu iecoris textus pro activitate pathologica longi hepatitis B nunc est virus velocissimum et potentissimum, mutatio rate infima analogorum nucleosiderum.Data ostendunt diversam aegros cum hepatitis longis B, incluso nucleoside rustica et nucleoside curata et aegros iecoris cirrhosis, bene entecavir tabulas in curatione moderari posse morbum celeriter et facilem curationem rei finis attingere, scilicet hepatitis B virus immensum;per adhaesionem curationi, magna portio aegrorum ad satisfaciendum curationis finem perveniri potest, nempe e serologia antigene conversionis, quidam aegros etiam attingere possunt specimen pro curatione finis, nempe superficies negativae antigenis.

Epistulam tuam hic scribe et mitte nobis